Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Panobinostat (LBH589) and Epirubicin in Patients With Solid Tumor Malignancies

NCT00878904 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00878904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00878904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Panobinostat (LBH589) and Epirubicin in Patients With Solid Tumor Malignancies
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
September 13, 2009
Completion date
October 10, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific